Global Plasma Protein Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

According to APO Research, The global Plasma Protein Therapeutics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Plasma Protein Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Plasma Protein Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Plasma Protein Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Plasma Protein Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Plasma Protein Therapeutics include Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Plasma Protein Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Plasma Protein Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for Plasma Protein Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasma Protein Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Plasma Protein Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Plasma Protein Therapeutics sales, projected growth trends, production technology, application and end-user industry.

Plasma Protein Therapeutics Segment by Company

Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada

Plasma Protein Therapeutics Segment by Type

Coagulation Factor
Immune Globulin
Albumin
Others

Plasma Protein Therapeutics Segment by Application

Hemophilia
PID
Others

Plasma Protein Therapeutics Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Protein Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Protein Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Protein Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plasma Protein Therapeutics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma Protein Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Plasma Protein Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Plasma Protein Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Plasma Protein Therapeutics Market Size, 2020 VS 2024 VS 2031
1.3 Global Plasma Protein Therapeutics Market Size Estimates and Forecasts (2020-2031)
1.4 Global Plasma Protein Therapeutics Sales Estimates and Forecasts (2020-2031)
1.5 Global Plasma Protein Therapeutics Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Plasma Protein Therapeutics Market Dynamics
2.1 Plasma Protein Therapeutics Industry Trends
2.2 Plasma Protein Therapeutics Industry Drivers
2.3 Plasma Protein Therapeutics Industry Opportunities and Challenges
2.4 Plasma Protein Therapeutics Industry Restraints
3 Plasma Protein Therapeutics Market by Manufacturers
3.1 Global Plasma Protein Therapeutics Revenue by Manufacturers (2020-2025)
3.2 Global Plasma Protein Therapeutics Sales by Manufacturers (2020-2025)
3.3 Global Plasma Protein Therapeutics Average Sales Price by Manufacturers (2020-2025)
3.4 Global Plasma Protein Therapeutics Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Plasma Protein Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Plasma Protein Therapeutics Manufacturers, Product Type & Application
3.7 Global Plasma Protein Therapeutics Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Plasma Protein Therapeutics Market CR5 and HHI
3.8.2 Global Top 5 and 10 Plasma Protein Therapeutics Players Market Share by Revenue in 2024
3.8.3 2024 Plasma Protein Therapeutics Tier 1, Tier 2, and Tier 3
4 Plasma Protein Therapeutics Market by Type
4.1 Plasma Protein Therapeutics Type Introduction
4.1.1 Coagulation Factor
4.1.2 Immune Globulin
4.1.3 Albumin
4.1.4 Others
4.2 Global Plasma Protein Therapeutics Sales by Type
4.2.1 Global Plasma Protein Therapeutics Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Plasma Protein Therapeutics Sales by Type (2020-2031)
4.2.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2031)
4.3 Global Plasma Protein Therapeutics Revenue by Type
4.3.1 Global Plasma Protein Therapeutics Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Plasma Protein Therapeutics Revenue by Type (2020-2031)
4.3.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2020-2031)
5 Plasma Protein Therapeutics Market by Application
5.1 Plasma Protein Therapeutics Application Introduction
5.1.1 Hemophilia
5.1.2 PID
5.1.3 Others
5.2 Global Plasma Protein Therapeutics Sales by Application
5.2.1 Global Plasma Protein Therapeutics Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Plasma Protein Therapeutics Sales by Application (2020-2031)
5.2.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2020-2031)
5.3 Global Plasma Protein Therapeutics Revenue by Application
5.3.1 Global Plasma Protein Therapeutics Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Plasma Protein Therapeutics Revenue by Application (2020-2031)
5.3.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2020-2031)
6 Global Plasma Protein Therapeutics Sales by Region
6.1 Global Plasma Protein Therapeutics Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Plasma Protein Therapeutics Sales by Region (2020-2031)
6.2.1 Global Plasma Protein Therapeutics Sales by Region (2020-2025)
6.2.2 Global Plasma Protein Therapeutics Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Plasma Protein Therapeutics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Plasma Protein Therapeutics Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Plasma Protein Therapeutics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Plasma Protein Therapeutics Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Plasma Protein Therapeutics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Plasma Protein Therapeutics Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Plasma Protein Therapeutics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Plasma Protein Therapeutics Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Plasma Protein Therapeutics Revenue by Region
7.1 Global Plasma Protein Therapeutics Revenue by Region
7.1.1 Global Plasma Protein Therapeutics Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Plasma Protein Therapeutics Revenue by Region (2020-2025)
7.1.3 Global Plasma Protein Therapeutics Revenue by Region (2026-2031)
7.1.4 Global Plasma Protein Therapeutics Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Plasma Protein Therapeutics Revenue (2020-2031)
7.2.2 North America Plasma Protein Therapeutics Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Plasma Protein Therapeutics Revenue (2020-2031)
7.3.2 Europe Plasma Protein Therapeutics Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Plasma Protein Therapeutics Revenue (2020-2031)
7.4.2 Asia-Pacific Plasma Protein Therapeutics Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Plasma Protein Therapeutics Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Plasma Protein Therapeutics Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Shire (Baxalta)
8.1.1 Shire (Baxalta) Comapny Information
8.1.2 Shire (Baxalta) Business Overview
8.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
8.1.5 Shire (Baxalta) Recent Developments
8.2 CSL
8.2.1 CSL Comapny Information
8.2.2 CSL Business Overview
8.2.3 CSL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 CSL Plasma Protein Therapeutics Product Portfolio
8.2.5 CSL Recent Developments
8.3 Grifols
8.3.1 Grifols Comapny Information
8.3.2 Grifols Business Overview
8.3.3 Grifols Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Grifols Plasma Protein Therapeutics Product Portfolio
8.3.5 Grifols Recent Developments
8.4 Octapharma
8.4.1 Octapharma Comapny Information
8.4.2 Octapharma Business Overview
8.4.3 Octapharma Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Octapharma Plasma Protein Therapeutics Product Portfolio
8.4.5 Octapharma Recent Developments
8.5 Kedrion
8.5.1 Kedrion Comapny Information
8.5.2 Kedrion Business Overview
8.5.3 Kedrion Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Kedrion Plasma Protein Therapeutics Product Portfolio
8.5.5 Kedrion Recent Developments
8.6 LFB Group
8.6.1 LFB Group Comapny Information
8.6.2 LFB Group Business Overview
8.6.3 LFB Group Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 LFB Group Plasma Protein Therapeutics Product Portfolio
8.6.5 LFB Group Recent Developments
8.7 Biotest
8.7.1 Biotest Comapny Information
8.7.2 Biotest Business Overview
8.7.3 Biotest Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Biotest Plasma Protein Therapeutics Product Portfolio
8.7.5 Biotest Recent Developments
8.8 BPL
8.8.1 BPL Comapny Information
8.8.2 BPL Business Overview
8.8.3 BPL Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 BPL Plasma Protein Therapeutics Product Portfolio
8.8.5 BPL Recent Developments
8.9 RAAS
8.9.1 RAAS Comapny Information
8.9.2 RAAS Business Overview
8.9.3 RAAS Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 RAAS Plasma Protein Therapeutics Product Portfolio
8.9.5 RAAS Recent Developments
8.10 CBPO
8.10.1 CBPO Comapny Information
8.10.2 CBPO Business Overview
8.10.3 CBPO Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 CBPO Plasma Protein Therapeutics Product Portfolio
8.10.5 CBPO Recent Developments
8.11 Hualan Bio
8.11.1 Hualan Bio Comapny Information
8.11.2 Hualan Bio Business Overview
8.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Hualan Bio Plasma Protein Therapeutics Product Portfolio
8.11.5 Hualan Bio Recent Developments
8.12 Kamada
8.12.1 Kamada Comapny Information
8.12.2 Kamada Business Overview
8.12.3 Kamada Plasma Protein Therapeutics Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Kamada Plasma Protein Therapeutics Product Portfolio
8.12.5 Kamada Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Plasma Protein Therapeutics Value Chain Analysis
9.1.1 Plasma Protein Therapeutics Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Plasma Protein Therapeutics Production Mode & Process
9.2 Plasma Protein Therapeutics Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Plasma Protein Therapeutics Distributors
9.2.3 Plasma Protein Therapeutics Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings